top of page
Search

Multiple Sclerosis, Gut Health & the Microbiome Case Study

  • 6 days ago
  • 4 min read

Multiple sclerosis (MS) is a complex autoimmune condition affecting the central nervous system, but increasing research suggests the gut microbiome may play a major role in immune regulation, systemic inflammation, and neurological health.

In this case study, we explore how advanced gut microbiome testing through Microbiotica and


Enbiosis was used to identify inflammatory patterns, poor microbiome diversity, impaired mitochondrial-supportive pathways, and potential dietary interventions for a patient with multiple sclerosis and ongoing gastrointestinal symptoms.

Rather than focusing solely on symptom management, the goal was to support the body more holistically by improving:

  • Gut health

  • Microbial diversity

  • Intestinal barrier integrity

  • Mitochondrial function

  • Nutritional status

  • Systemic inflammation


This approach combined personalised nutrition, targeted supplementation, microbiome analysis, and foundational anti-inflammatory support.


Why Gut Health Matters in Multiple Sclerosis

Emerging evidence continues to highlight the relationship between the gut microbiome and autoimmune disease. The gastrointestinal tract plays a major role in immune system signalling, inflammatory regulation, nutrient absorption, and even neurological communication through the gut-brain axis.

The patient presented with:

  • Multiple sclerosis

  • Digestive discomfort

  • Signs of poor microbiome diversity

  • Potential inflammatory gut patterns

  • Reduced mitochondrial-supportive microbial activity

Because gut dysfunction can contribute to immune dysregulation and systemic inflammation, improving gastrointestinal health became a central focus of the intervention.


Advanced Gut Testing with Microbiotica & Enbiosis

To gain a deeper understanding of the patient’s microbiome, advanced testing was performed using both Microbiotica and Enbiosis platforms.

These tests provided insight into:

  • Microbial diversity

  • Functional bacterial activity

  • Diet-microbiome interactions

  • Inflammatory tendencies

  • Food recommendations

  • Mitochondrial-supportive pathways



One of the most notable findings was the patient’s extremely low microbiome diversity score of 0.5, suggesting a highly compromised microbial ecosystem.

Low diversity is commonly associated with:

  • Autoimmune conditions

  • Chronic inflammation

  • Reduced resilience

  • Poor gut barrier function

  • Reduced short-chain fatty acid production


The Enbiosis report highlighted that the patient’s microbiome profile aligned more closely with patterns seen in autoimmune conditions compared to healthy individuals.

Additional findings also suggested microbial patterns similar to those often seen in individuals exposed to antibiotic-associated microbiome disruption.



Personalised Nutrition Strategy

One of the advantages of Enbiosis testing is its ability to generate highly personalised food recommendations based on the individual’s microbiome profile.

Rather than using a generic elimination diet, foods were selected based on their predicted ability to positively influence microbial balance and improve diversity.

Recommended foods included:

  • Apples

  • Kiwi

  • Onion

  • Whole grains

  • Carrot juice

  • Raisins

  • Redcurrants

Many of these foods are rich in:

  • Polyphenols

  • Prebiotic fibres

  • Antioxidants

  • Fermentable compounds that support beneficial bacteria

The intention was to gradually improve microbial diversity while also supporting gut barrier integrity and reducing inflammatory stress.


The Ellagic Acid & Urolithin A Connection

One particularly interesting finding involved the patient’s response to pomegranate extract (ellagitannins and ellagic acid).


Due to the reduced conversion score, direct urolithin A supplementation was introduced to bypass microbiome limitations and provide direct mitochondrial support.

The rationale included supporting:

  • Cellular energy production

  • Neurological resilience

  • Mitochondrial efficiency

  • Fatigue management

  • Healthy aging pathways

While no supplement should be viewed as a cure for autoimmune disease, supporting mitochondrial function may play a useful role in improving overall resilience and energy metabolism in chronic inflammatory conditions.


Curcumin for Gut & Systemic Inflammation

Alongside microbiome-focused interventions, a broader anti-inflammatory strategy was implemented using curcumin, which scored 8/10 within the patient’s personalised microbiome recommendations.

Curcumin was selected due to its potential effects on:

  • NF-kB signalling

  • Oxidative stress

  • Inflammatory pathways

  • Gut barrier integrity

  • Neurological health

Because inflammation appeared to be a major contributing factor within both the gut and autoimmune profile, curcumin became one of the core foundational interventions within the protocol.

As the patient may later progress onto more advanced health optimisation testing such as TruHealth, the initial goal was to establish strong foundational anti-inflammatory support in a cost-effective manner before expanding into more advanced biomarker analysis.

This “foundational first” approach helps reduce unnecessary testing costs while still targeting key drivers of inflammation and dysfunction early on.


Colostrum for Gut Barrier Repair

To further support gastrointestinal healing, the protocol also included a high-quality colostrum supplement.

Particular attention was placed on sourcing colostrum that had undergone minimal heat exposure during manufacturing in order to preserve more of its naturally occurring bioactive compounds, immunoglobulins, peptides, and growth factors.

Colostrum was selected for its potential benefits involving:

  • Gut barrier integrity

  • Immune modulation

  • Gastrointestinal recovery

  • Reduction of intestinal permeability

  • Growth factor support

  • Mucosal healing

Because the patient displayed signs of significant microbiome dysfunction and poor diversity, improving gut barrier resilience became a major therapeutic target.


High Ginger Intake for Digestive & Inflammatory Support

The patient also implemented a relatively high intake of ginger as part of the gut-healing and anti-inflammatory protocol.

Ginger was chosen due to its potential effects on:

  • Digestive motility

  • Gastrointestinal comfort

  • Nausea reduction

  • Reduction in inflammatory signalling

  • Antioxidant support

Since digestive symptoms were a major concern, ginger provided both functional digestive support and broader systemic anti-inflammatory benefits.

Combining ginger with curcumin and microbiome-targeted nutrition created a more comprehensive strategy aimed at reducing inflammatory stress while improving gastrointestinal function.


A Systems-Based Approach to Autoimmune Health

More on the Enbiosis gut microbiome test:


This case highlights the growing importance of looking beyond isolated symptoms and instead examining the interconnected systems involved in autoimmune disease.

Rather than focusing on a single intervention, the strategy aimed to support multiple areas simultaneously:

  • Gut microbiome diversity

  • Gastrointestinal integrity

  • Immune regulation

  • Inflammatory balance

  • Mitochondrial function

  • Nutritional resilience


While this remains an ongoing case, the initial findings strongly suggest that advanced microbiome testing can provide valuable insights into personalised dietary and supplement strategies for individuals with complex autoimmune and inflammatory conditions.

As research into the gut-brain-immune connection continues to evolve, personalised microbiome interventions may become an increasingly important component of functional and preventative healthcare approaches for conditions such as multiple sclerosis.

Future stages of this case study will explore symptom progression, dietary adherence, further biomarker analysis, and the potential integration of advanced longevity and epgenetic testing through platforms such as TruHealth.


 
 
 

Comments


© 2025 by Epic Genetics Limited

bottom of page